Amgen IncChange company Symbol lookupSelect an option...AMGN Amgen IncGSBD Goldman Sachs BDC IncLTRN Lantern Pharma IncJGGC Jaguar Global Growth Corporation IWHG Westwood Holdings Group IncBNOX Bionomics LtdPSO Pearson PLCERNA Eterna Therapeutics IncINDP Indaptus Therapeutics IncTSLX Sixth Street Specialty Lending IncGo
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq), Evenity, LumaKras, Nplate, XGeva, and others. The Company focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| August 3, 2023 | Q2 2023 Earnings Release | $5.00 | $3.92 to $4.84 | $4.65 |
| April 27, 2023 | Q1 2023 Earnings Release | $3.98 | $3.30 to $4.49 | $4.25 |
| January 31, 2023 | Q4 2022 Earnings Release | $4.09 | $3.94 to $4.25 | $4.36 |
| November 3, 2022 | Q3 2022 Earnings Release | $4.70 | $4.23 to $4.75 | $4.67 |
Past Dividends
| Ex-dividend date | Amount | Record date | Pay date |
|---|---|---|---|
| August 17, 2023 | $2.13 | August 18, 2023 | September 8, 2023 |
| May 17, 2023 | $2.13 | May 18, 2023 | June 8, 2023 |
| February 14, 2023 | $2.13 | February 15, 2023 | March 8, 2023 |
| November 16, 2022 | $1.94 | November 17, 2022 | December 8, 2022 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.